Mayo Clinic Tests Platelet Rich Plasma for Facial and Hand Skin Rejuvenation

Mayo Clinic researchers completed a pilot study investigating platelet rich plasma (PRP) as a regenerative therapy for aging skin in women. The trial aimed to evaluate both the safety and efficacy of using PRP to treat facial and hand skin aging, conditions that significantly impact quality of life and self-confidence as people age.

The study enrolled 12 female participants who received PRP treatments targeting aging skin on their faces and hands. PRP is created by concentrating platelets from a patient's own blood, which are rich in growth factors and proteins that naturally promote tissue healing and regeneration. This autologous approach minimizes rejection risks while potentially stimulating collagen production and cellular renewal.

The trial ran from June 2019 to June 2021, allowing researchers sufficient time to assess both immediate and longer-term effects of the treatment. As a pilot study, this research was designed to establish preliminary safety data and treatment protocols rather than provide definitive efficacy results.

This research represents part of a growing field in regenerative medicine focused on harnessing the body's natural healing mechanisms to address age-related changes. Skin aging involves decreased collagen production, reduced cellular turnover, and diminished repair capacity - all processes that PRP's growth factors might theoretically improve.

While the study has completed, detailed results haven't been published yet. The findings could inform larger clinical trials and help establish whether PRP represents a viable, minimally invasive option for skin rejuvenation. For longevity-focused individuals, this research explores whether regenerative approaches can effectively address visible signs of aging while potentially improving underlying skin health and function.